AFP and hepatocellular carcinoma: In addition, CTC‐related variables were especially helpful in AFP‐negative patients; 70 out of 156 HCC patients in the cohort (44.87%), 16 of whom had no warning biomarkers, exhibited tumor recurrence, but all of them could be identified by the CTC numbers or PCP.